Search results

908 results

Sorted by Relevance . Sort by Date

  1. New lung cancer treatment option approved by NICE

    Another new life-extending treatment for some people with lung cancer is to be made available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (8 August 2019).

  2. Involved & informed: good community medicines support

    The National Institute for Health and Care Excellence (NICE), in collaboration with several other partner organisations, has launched a new initiative to encourage better medicines support for people who are receiving social care services in their homes.

  3. Spinraza access agreement extended

    More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza after NICE today (3 July) published amended draft guidance following a proposal for extending the terms of the managed access agreement (MAA) between NHS England and Biogen for funding it.

  4. Limit spread of blood-borne viruses among steroid users

    Needle and syringe programmes should support the growing number of image and performance enhancing drug users so they can be offered sterile equipment to reduce the spread of blood-borne viruses and infections from contaminated needles, says NICE.